Articles by Jim Miller - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Jim Miller

What to Watch For in 2011

CDMOs and CMOs face weak economic recovery, consolidation, and globalization.
Jan 1, 2011

CDMOs and CMOs face weak economic recovery, consolidation, and globalization.

Winning Big

Covance's deal with Sanofi-Aventis demonstrates the power of scale and scope.
Dec 1, 2010

Covance's deal with Sanofi-Aventis demonstrates the power of scale and scope.

Uncertain Outlook for Biopharma Venture Capital

Venture capital is still scarce for early biotechs and their providers.
Oct 1, 2010

Venture capital is still scarce for early biotechs and their providers.

Spanning the Globe

This month, we catch up on major developments around the world and their implications for the contract services industry.
Aug 1, 2010

This month, we catch up on major developments around the world and their implications for the contract services industry.

How Outsourcing Can Accelerate Early CMC Development

How much to spend on early development, whether to use your CMO's proprietary cell line, and other outsourcing advice.
Jul 1, 2010

How much to spend on early development, whether to use your CMO's proprietary cell line, and other outsourcing advice.

Out of Nowhere: Do You Need to Prepare for Highly Improbable Situations?

Being open to unforseen events may avert risk or create opportunities.
Jun 1, 2010

Being open to unforseen events may avert risk or create opportunities.

Complex Clinical Trials are Posing New Challenges Across the Clinical Supply Chain

The ability to deal with the complexity of the clinical supply process has shifted the balance of power to clinical supply chain specialists.
Apr 1, 2010

The ability to deal with the complexity of the clinical supply process has shifted the balance of power to clinical supply chain specialists.

Cautious Hopefullness: Contract Services Industry's Fortunes Unclear for 2010

As facility closures and layoffs continue, CRO and CMO executives are hoping for a better year, despite few positive signs.
Feb 1, 2010

As facility closures and layoffs continue, CRO and CMO executives are hoping for a better year, despite few positive signs.

CDMOs Benefit from the Growing Biologics Market

A new analysis highlights growth opportunities and challenges for contract development and manufacturing organizations.
Dec 1, 2009

A new analysis highlights growth opportunities and challenges for contract development and manufacturing organizations.

ADVERTISEMENT

ADVERTISEMENT

Click here